Czech National Bank’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.4M Buy
109,834
+5,018
+5% +$334K 0.04% 335
2026
Q1
$6.58M Buy
104,816
+1,974
+2% +$137K 0.04% 336
2025
Q4
$6.83M Buy
102,842
+3,242
+3% +$210K 0.04% 320
2025
Q3
$6.7M Buy
99,600
+3,755
+4% +$297K 0.05% 313
2025
Q2
$8.37M Buy
95,845
+6,108
+7% +$479K 0.07% 258
2025
Q1
$6.13M Buy
89,737
+5,048
+6% +$412K 0.06% 296
2024
Q4
$6.59M Buy
84,689
+3,057
+4% +$226K 0.06% 282
2024
Q3
$5.47M Buy
81,632
+5,850
+8% +$480K 0.06% 303
2024
Q2
$8.59M Buy
75,782
+7,951
+12% +$1.01M 0.1% 189
2024
Q1
$9.41M Buy
67,831
+160
+0.2% +$20.1K 0.12% 166
2023
Q4
$8.4M Sell
67,671
-121
-0.2% -$12.4K 0.12% 169
2023
Q3
$6.32M Buy
67,792
+21,904
+48% +$2.47M 0.1% 208
2023
Q2
$5.9M Buy
45,888
+340
+0.7% +$41.1K 0.13% 146
2023
Q1
$5.29M Buy
45,548
+336
+0.7% +$37.6K 0.13% 165
2022
Q4
$5.12M Sell
45,212
-412
-0.9% -$45.2K 0.14% 167
2022
Q3
$3.67M Buy
+45,624
New +$3.86M 0.11% 206

Other funds holding DXCM

Czech National Bank's DXCM Position: Q2 2026 in Review

Czech National Bank increased its DexCom (DXCM) stake by 4.8% in Q2 2026, buying an estimated $334K and bringing the position to 109,834 shares worth $7.4M. The position accounts for 0.04% of the portfolio, ranked #335.

Czech National Bank first reported a position in DXCM in Q3 2022 and has held it in 16 quarters since. The position peaked at $9.41M in Q1 2024. 496 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Czech National Bank held 109,834 shares of DexCom worth $7.4M as of Q2 2026.
  • Czech National Bank bought 5,018 DexCom shares in Q2 2026, an estimated $334K.
  • DexCom made up 0.04% of Czech National Bank's portfolio in Q2 2026, its #335 holding.
  • Czech National Bank first reported a position in DexCom in Q3 2022 and has held it in 16 quarters since.
  • Czech National Bank's DexCom position peaked at $9.41M in Q1 2024.
  • 496 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.